T1	p 401 418	cigarettes smoked
T2	p 654 657	for
T3	p 709 772	USA . PARTICIPANTS A total of 403 adult , daily smokers without
T4	i 33 70	bupropion sustained-release treatment
T5	i 174 218	bupropion sustained-release ( SR ) treatment
T6	i 550 568	placebo-controlled
T7	i 587 599	bupropion SR
T8	i 694 701	Madison
T9	i 704 706	WI
T10	i 794 806	bupropion SR
T11	i 892 924	bupropion SR or placebo pill and
T12	i 936 997	eight brief individual counseling sessions or no counseling .
T13	i 1062 1070	behavior
T14	i 1161 1169	equation
T15	i 1237 1259	bupropion SR treatment
T16	i 1696 1708	bupropion SR
T17	o 75 82	smoking
T18	o 282 411	post-quit abstinence , including withdrawal distress , cigarette craving , positive affect and subjective reactions to cigarettes
T19	o 440 451	specificity
T20	o 465 475	SR effects
T21	o 1043 1093	ratings of smoking behavior and putative mediators
T22	o 1280 1290	abstinence
T23	o 1303 1322	withdrawal distress
T24	o 1340 1358	subjective effects
T25	o 1428 1468	cigarette craving reduction and enhanced
T26	o 1511 1538	point-prevalence abstinence
T27	o 1601 1639	motivation to quit and self-efficacy .
T28	o 1723 1730	relapse